Capillary Biomedical is developing a novel infusion set for use with insulin pumps for the intensive management of diabetes. The company has assembled a veteran team of diabetes technology entrepreneurs, conducted extensive preclinical research, developed a minimal viable product, and filed multiple patent applications. The company recently completed a series seed preferred equity financing led by the Cove Fund of Orange County and syndicated among leading angel groups. Funds will be used for clinical trials and regulatory clearance leading to commercial launch in 2019.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/14/18 | $2,900,000 | Seed |
ACE Fund HBS Alumni Angels of Greater New York Mass Medical Angels New York Angels NYA Fund PA Fund Pasadena Angels Tech Coast Angels The Cove Fund  | undisclosed |
